Peer to Peer

Using Patch Testing to Identify Culprit Agents in Suspected Drug Eruptions

Publish date: February 7, 2017
By
Susan T. Nedorost, MD
Author and Disclosure Information

In this edition of the "Peer to Peer" audiocast series, Dr. Vincent DeLeo speaks with Dr. Susan T. Nedorost about using patch testing as a diagnostic tool for suspected drug eruptions. Dr. Nedorost discusses challenges dermatologists may encounter when using patch testing in cohorts that present with potential drug eruptions and describes settings in which this technique may be most useful for patients. She also emphasizes that drug reactions sometimes may be caused by the product's excipients, not the drug itself.

 

Recommended Reading

Most Common Dermatologic Conditions Encountered by Dermatologists and Nondermatologists
MDedge Dermatology
Cholinergic Urticaria With Anaphylaxis: Hazardous Duty of a Deployed US Marine
MDedge Dermatology
Mycoplasma pneumoniae Infection in Adults With Acute and Chronic Urticaria
MDedge Dermatology
Pruritic Urticarial Papules and Plaques of Pregnancy Occurring Postpartum
MDedge Dermatology
Dermatologic Emergencies
MDedge Dermatology
Manage Your Dermatology Practice: Answering Patient Questions About Diet
MDedge Dermatology
Diagnosis and Management of Cold Urticaria
MDedge Dermatology
Dermatologists Should Get the Point: Acupuncture for the Treatment of Skin Disorders
MDedge Dermatology
Tryptase gene variant linked to GI, joint, and skin symptoms
MDedge Dermatology
Don’t miss these drug reactions
MDedge Dermatology

Related Articles